Nebenwirkungen · Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop)
Irbesartan Hydrochlorothiazide Zentiva 300 mg/12.5 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 27
HOS-118036 · Präparat HOS-094733
Table 1: Adverse Reactions in Placebo-Controlled Trials and Spontaneous Reports Investigations: Common: increases in blood urea nitrogen (BUN), creatinine and creatine kinase Uncommon: decreases in serum potassium and sodium Cardiac disorders: Uncommon: syncope, hypotension, tachycardia, oedema Nervous system disorders: Common: dizziness Uncommon: orthostatic dizziness Not known: headache Ear and labyrinth disorders: Not known: tinnitus Respiratory, thoracic and Not known: cough mediastinal disorders: Gastrointestinal disorders: Common: nausea/vomiting Uncommon: diarrhoea Not known: dyspepsia, dysgeusia Renal and urinary disorders: Common: abnormal urination Not known: impaired renal function including isolated cases of renal failure in patients at risk (see section 4.4) Musculoskeletal and connective Uncommon: swelling extremity tissue disorders: Not known: arthralgia, myalgia Metabolism and nutrition Not known: hyperkalaemia disorders: Vascular disorders: Uncommon: flushing General disorders and Common: fatigue administration site conditions: Immune system disorders: Not known: cases of hypersensitivity reactions such as angioedema, rash, urticaria
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-04T14:02:00Z · SHA-256 a042eb891ea2c5486827adad4aa2697b20f0615135f11f14a4bb7f7559935cbd · Passage 6906f033677dedd69f2fd4038534fda3776651b3fa689d37aa94d9954f25612a · Zeichen 1033–3001 im Abschnitt